Back to Search
JADE HOMSI, MD
MD
Hematology & Oncology Physician
NPI: 1154346963IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
331578(NY)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1995
Research & Publications (20)
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
PMID 19521262·Melanoma Res·2009
3-trial
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
PMID 19506454·Am J Clin Oncol·2009
3-trial
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
PMID 19440934·Cancer Invest·2009
3-trial
Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.
PMID 19434004·Melanoma Res·2009
8-other
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies.
PMID 17908979·Clin Cancer Res·2007
3-trial
Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors.
PMID 17615535·Cancer Control·2007
6-review
The Src signaling pathway: a potential target in melanoma and other malignancies.
PMID 17150037·Expert Opin Ther Targets·2007
6-review
Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.
PMID 16508625·Cancer Control·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 750 E. ADAMS ST.
SYRACUSE, NY 13210 - Phone
- (315) 464-8200
Quick Facts
- NPI
- 1154346963
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile